Počet záznamov: 1
syndróm eozinofilný myalgický
SYS d016603 LBL 00000cz--a2200000n--4500 005 20250606214405.4 008 920125|||anznnbabn-----------|-a|a------ 040 $b slo $a DNLM $d BA006 $d BA006 $d BA006 065 $a C05.651.290 065 $a C10.668.491.050 065 $a C15.378.553.231.335 066 $a 01 $c 03 150 $a syndróm eozinofilný myalgický $x BL $x CF $x CI $x CL $x CN $x CO $x DG $x DH $x DI $x DT $x EC $x EH $x EM $x EN $x EP $x ET $x GE $x HI $x IM $x ME $x MI $x MO $x NU $x PA $x PC $x PP $x PS $x PX $x RH $x RT $x SU $x TH $x UR $x VE $x VI $2 slo 450 $w v $a syndróm eozinofilný myalgický, súvisiaci s L-tryptofánom $2 slo 450 $w v $a syndróm eozinofília-myalgia $2 slo 550 $7 sllk_us_auth*d014364 $Y Tryptophan $w b $a tryptofán 665 $a 92 $2 eng 665 $a Eosinophilia/chemically induced (1989-1990) $2 eng 665 $a Muscular Diseases/chemically induced (1990) $2 eng 665 $a Tryptophan/adverse effects (1989-1990) $2 eng 680 9-
$i A complex systemic syndrome with inflammatory and autoimmune components that affect the skin, fascia, muscle, nerve, blood vessels, lung, and heart. Diagnostic features generally include EOSINOPHILIA, myalgia severe enough to limit usual activities of daily living, and the absence of coexisting infectious, autoimmune or other conditions that may induce eosinophilia. Biopsy of affected tissue reveals a microangiopathy associated with diffuse inflammation involving connective tissue. (From Spitzer et al., J Rheumatol Suppl 1996 Oct;46:73-9; Blackburn WD, Semin Arthritis Rheum 1997 Jun;26(6):788-93) $2 eng 750 -2
$a Eosinophilia-Myalgia Syndrome $2 eng 980 $x M
Počet záznamov: 1